Literature DB >> 18836078

The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system.

Ronen Sadeh1, Kristin Breitschopf, Beatrice Bercovich, Muhammad Zoabi, Yelena Kravtsova-Ivantsiv, Daniel Kornitzer, Alan Schwartz, Aaron Ciechanover.   

Abstract

A growing number of proteins, including the myogenic transcription factor MyoD, are targeted for proteasomal degradation after N-terminal ubiquitination (NTU) where the first ubiquitin moiety is conjugated to the N-terminal residue rather than to an internal lysine. NTU might be essential in targeting both lysine-containing and naturally occurring lysine-less proteins such as p16(INK4a) and p14(ARF); however, the mechanisms that underlie this process are largely unknown. Specifically, the recognition motif(s) in the target substrates and the ubiquitin ligase(s) that catalyze NTU are still obscure. Here we show that the N-terminal domain of MyoD is critical for its degradation and that its destabilizing effect depends on nuclear localization of the protein. Deletion of the first 15 aa of MyoD blocked completely its lysine-independent degradation. Importantly, transfer of the first 30 N-terminal residues of MyoD to GFP destabilized this otherwise stable protein, and, here too, targeting for degradation depended on localization of the protein to the nucleus. Deletion of the N-terminal domain of lysine-less MyoD did not abolish completely ubiquitination of the protein, suggesting that this domain may be required for targeting the protein also in a postubiquitination step. Interestingly, NTU is evolutionarily conserved: in the yeast Saccharomyces cerevisiae lysine-less (LL) MyoD is degraded in a ubiquitin-, N-terminal domain-, and nuclear localization-dependent manner. Taken together, our data suggest that a short N-terminal segment of MyoD is necessary and sufficient to render MyoD susceptible for ubiquitin- and nuclear-dependent degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836078      PMCID: PMC2560994          DOI: 10.1073/pnas.0808373105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The nuclear ubiquitin-proteasome system degrades MyoD.

Authors:  Z E Floyd; J S Trausch-Azar; E Reinstein; A Ciechanover; A L Schwartz
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

2.  ATP-dependent proteases degrade their substrates by processively unraveling them from the degradation signal.

Authors:  C Lee; M P Schwartz; S Prakash; M Iwakura; A Matouschek
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

3.  Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization.

Authors:  Z Lai; K V Ferry; M A Diamond; K E Wee; Y B Kim; J Ma; T Yang; P A Benfield; R A Copeland; K R Auger
Journal:  J Biol Chem       Date:  2001-06-07       Impact factor: 5.157

4.  Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover.

Authors:  B R Henderson
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

Review 5.  Protein targeting to ATP-dependent proteases.

Authors:  Tomonao Inobe; Andreas Matouschek
Journal:  Curr Opin Struct Biol       Date:  2008-02-13       Impact factor: 6.809

6.  Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.

Authors:  S Aviel; G Winberg; M Massucci; A Ciechanover
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

7.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.

Authors:  R J Sheaff; J D Singer; J Swanger; M Smitherman; J M Roberts; B E Clurman
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

8.  Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue.

Authors:  E Reinstein; M Scheffner; M Oren; A Ciechanover; A Schwartz
Journal:  Oncogene       Date:  2000-11-30       Impact factor: 9.867

Review 9.  The mammalian N-end rule pathway: new insights into its components and physiological roles.

Authors:  Takafumi Tasaki; Yong Tae Kwon
Journal:  Trends Biochem Sci       Date:  2007-10-24       Impact factor: 13.807

10.  Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment.

Authors:  Stephen W G Tait; Evert de Vries; Chiel Maas; Anna M Keller; Clive S D'Santos; Jannie Borst
Journal:  J Cell Biol       Date:  2007-12-31       Impact factor: 10.539

View more
  10 in total

1.  Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein.

Authors:  Candace Bichsel; Dennis Neeld; Takashi Hamazaki; Lung-Ji Chang; Li-Jun Yang; Naohiro Terada; Shouguang Jin
Journal:  Cell Reprogram       Date:  2013-02-25       Impact factor: 1.987

2.  KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.

Authors:  Lauren R Combs; Lauren McKenzie Spires; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

Review 3.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

4.  Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis.

Authors:  Jonathan M D Vosper; Gary S McDowell; Christopher J Hindley; Christelle S Fiore-Heriche; Romana Kucerova; Ian Horan; Anna Philpott
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

5.  Ubiquitination of human AP-endonuclease 1 (APE1) enhanced by T233E substitution and by CDK5.

Authors:  Carlos S Busso; Courtney M Wedgeworth; Tadahide Izumi
Journal:  Nucleic Acids Res       Date:  2011-07-03       Impact factor: 16.971

6.  A perturbed ubiquitin landscape distinguishes between ubiquitin in trafficking and in proteolysis.

Authors:  Inbal Ziv; Yulia Matiuhin; Donald S Kirkpatrick; Zoi Erpapazoglou; Sebastien Leon; Marina Pantazopoulou; Woong Kim; Steven P Gygi; Rosine Haguenauer-Tsapis; Noa Reis; Michael H Glickman; Oded Kleifeld
Journal:  Mol Cell Proteomics       Date:  2011-03-22       Impact factor: 5.911

7.  Lysine-Less Variants of Spinal Muscular Atrophy SMN and SMNΔ7 Proteins Are Degraded by the Proteasome Pathway.

Authors:  Raúl Sánchez-Lanzas; José G Castaño
Journal:  Int J Mol Sci       Date:  2017-12-08       Impact factor: 5.923

Review 8.  Antiviral activity of innate immune protein ISG15.

Authors:  Ronald N Harty; Paula M Pitha; Atsushi Okumura
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

Review 9.  Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways.

Authors:  Umar-Faruq Cajee; Rodney Hull; Monde Ntwasa
Journal:  Int J Mol Sci       Date:  2012-09-19       Impact factor: 6.208

10.  Nandrolone-induced nuclear accumulation of MyoD protein is mediated by Numb, a Notch inhibitor, in C2C12 myoblasts.

Authors:  Xin-Hua Liu; Rita De Gasperi; William A Bauman; Christopher P Cardozo
Journal:  Physiol Rep       Date:  2018-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.